PT83192B - Process for preparing unsaturated compounds useful in the treatment of cardiovascular phatological conditions containing 1,4-di-hydropiridine-3,5-dicarboxylic acid derivatives - Google Patents
Process for preparing unsaturated compounds useful in the treatment of cardiovascular phatological conditions containing 1,4-di-hydropiridine-3,5-dicarboxylic acid derivativesInfo
- Publication number
- PT83192B PT83192B PT83192A PT8319286A PT83192B PT 83192 B PT83192 B PT 83192B PT 83192 A PT83192 A PT 83192A PT 8319286 A PT8319286 A PT 8319286A PT 83192 B PT83192 B PT 83192B
- Authority
- PT
- Portugal
- Prior art keywords
- phatological
- hydropiridine
- cardiovascular
- treatment
- dicarboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Liquid Crystal Substances (AREA)
- Paper (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH350485 | 1985-08-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT83192A PT83192A (en) | 1986-09-01 |
| PT83192B true PT83192B (en) | 1988-09-22 |
Family
ID=4257414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT83192A PT83192B (en) | 1985-08-14 | 1986-08-13 | Process for preparing unsaturated compounds useful in the treatment of cardiovascular phatological conditions containing 1,4-di-hydropiridine-3,5-dicarboxylic acid derivatives |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4808603A (pt) |
| EP (1) | EP0214094A1 (pt) |
| JP (1) | JPS6239569A (pt) |
| KR (1) | KR870002077A (pt) |
| AU (1) | AU6110386A (pt) |
| DD (1) | DD258604A5 (pt) |
| DK (1) | DK386086A (pt) |
| ES (1) | ES2000865A6 (pt) |
| FI (1) | FI863238A (pt) |
| GR (1) | GR862105B (pt) |
| HU (1) | HU196961B (pt) |
| NO (1) | NO863269L (pt) |
| PT (1) | PT83192B (pt) |
| ZA (1) | ZA866082B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63135381A (ja) * | 1986-11-26 | 1988-06-07 | Kyorin Pharmaceut Co Ltd | 多剤耐性癌細胞に対する感受性増強剤及びその製造方法 |
| US5434179A (en) * | 1989-06-06 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Method for improving brain function using cholinesterase-inhibiting aminoketone compounds |
| JP2861274B2 (ja) * | 1989-06-06 | 1999-02-24 | 武田薬品工業株式会社 | アミノケトン誘導体 |
| FR2671349B1 (fr) * | 1991-01-09 | 1993-04-23 | Lafon Labor | Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0145956A1 (de) * | 1983-11-16 | 1985-06-26 | Ciba-Geigy Ag | Neue Amid-Verbindungen |
| JPS60156671A (ja) * | 1984-01-25 | 1985-08-16 | Yamanouchi Pharmaceut Co Ltd | ジヒドロピリジン誘導体およびその製造法 |
-
1986
- 1986-08-07 US US06/895,604 patent/US4808603A/en not_active Expired - Fee Related
- 1986-08-08 EP EP86810349A patent/EP0214094A1/de not_active Withdrawn
- 1986-08-08 FI FI863238A patent/FI863238A/fi not_active Application Discontinuation
- 1986-08-11 GR GR862105A patent/GR862105B/el unknown
- 1986-08-12 DD DD86293596A patent/DD258604A5/de not_active IP Right Cessation
- 1986-08-12 ES ES8601041A patent/ES2000865A6/es not_active Expired
- 1986-08-13 NO NO863269A patent/NO863269L/no unknown
- 1986-08-13 PT PT83192A patent/PT83192B/pt unknown
- 1986-08-13 HU HU863574A patent/HU196961B/hu not_active IP Right Cessation
- 1986-08-13 AU AU61103/86A patent/AU6110386A/en not_active Abandoned
- 1986-08-13 DK DK386086A patent/DK386086A/da not_active Application Discontinuation
- 1986-08-13 ZA ZA866082A patent/ZA866082B/xx unknown
- 1986-08-14 JP JP61189711A patent/JPS6239569A/ja active Pending
- 1986-08-14 KR KR1019860006713A patent/KR870002077A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT41733A (en) | 1987-05-28 |
| GR862105B (en) | 1986-12-30 |
| DK386086D0 (da) | 1986-08-13 |
| FI863238A (fi) | 1987-02-15 |
| KR870002077A (ko) | 1987-03-30 |
| ES2000865A6 (es) | 1988-03-16 |
| ZA866082B (en) | 1987-03-25 |
| EP0214094A1 (de) | 1987-03-11 |
| US4808603A (en) | 1989-02-28 |
| NO863269D0 (no) | 1986-08-13 |
| AU6110386A (en) | 1987-02-19 |
| PT83192A (en) | 1986-09-01 |
| HU196961B (en) | 1989-02-28 |
| DD258604A5 (de) | 1988-07-27 |
| NO863269L (no) | 1987-02-16 |
| FI863238A0 (fi) | 1986-08-08 |
| DK386086A (da) | 1987-02-15 |
| JPS6239569A (ja) | 1987-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT82342A (en) | Process for the preparation of hialuronic acid derivatives | |
| PT81117B (en) | Process for preparing 1,4-di-hydropyridine-3,5-dicarboxylic acid derivatives | |
| PT86433A (en) | Process for the preparation of thiol-carboxylic acid derivatives | |
| PT82384A (en) | Process for preparing substituted 2,3,4,9-tetra-hydro-1h-carbazole-1-acetic acid derivatives | |
| HUT46021A (en) | Process for producing ceph-3-eme-4-carboxylic acid derivatives | |
| DE3665859D1 (en) | Process for producing 2,6-naphthalenedicarboxylic acid | |
| HUT45972A (en) | Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers | |
| DE3561054D1 (en) | Process for the preparation of 2,4-dichloro-5-fluoro-benzoic acid | |
| PT83192A (en) | Process for preparing unsaturated compounds useful in the treatment of cardiovascular phatological conditions containing 1,4-di-hydropiridine-3,5-dicarboxylic acid derivatives | |
| HUT45030A (en) | Process for production of derivatives of 5-aryl-2,4-dialkil-3h-1,2,4-triasole-3-tion | |
| HUT46023A (en) | Process for producing purin-9-yl-alkoxy-methyl-phosphonic acid derivatives | |
| HUT44273A (en) | Process for production of new derivatives of 16,17-acetal-substituted pregnane-21-carbonic acid | |
| EP0179654A3 (en) | Process for the preparation of 5,6,7,8-tetrahydrofolic acid | |
| HUT46327A (en) | Process for producing 3-(alkanoyl-oxy-methyl)-3-cefem-4-carboxylic acid derivatives | |
| EP0285972A3 (en) | Process for the preparation of 2,4-diaminobenzenesulfonic acid | |
| HUT48795A (en) | Acarycides containing 2,3-diamin malein acid nitril azomethin and process for production of these compositions | |
| PL248314A1 (en) | Process for preparing derivatives of bicyclo/3,2,1/-octano-3-carboxylic acid | |
| HU906329D0 (en) | Process for producing pyridyl-cyclopropane-carboxylic acid derivatives | |
| PT86143A (en) | Process for the preparation of guanidinomethylbenzoic acid derivatives | |
| PT83674A (en) | Process for preparing 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives | |
| HUT47262A (en) | Process for production of derivatives of 2,1-benzotiazepin-2,2-dioxid-5-carbonic acid | |
| PT82508A (en) | Process for preparing 2-acylaminomethyl-2-penem-3-carboxylic acid derivatives | |
| HUT43029A (en) | Process for preparing 5,6-dialkoxy-anthranilic acid derivatives | |
| EP0186629A3 (en) | Process for the preparation of 3,5-dialkyl-4-hydroxybenzoic acid | |
| PT83038A (en) | Process for preparing antihypertensive agents containing 1,7-naphthyridine-3-carboxylic acid derivatives |